Patenting antibodies: a personal take on maturing technology
An update from CET 5 Biotechnology and Pharmaceuticals
14 Jul 2025
0
As the tools for generating and characterising antibodies become more sophisticated and widely available, patent offices are re-evaluating how they assess key legal requirements such as inventiveness and sufficiency of disclosure....
Foreign Filing License requirements under Pakistani patent law: a Critical Compliance Guide
08 Jul 2025
0
When Pakistani residents are involved in the patent application process, there are crucial legal requirements that...
READ MORE
Analysing the results of PMC's IP management tools survey: are they delivering what today’s firms need?
13 Jun 2025
0
Insights from a FICPI survey on IP management systems: IP management has moved from back-office function...
READ MORE
Türkiye: recent amendment to the regulation on the IP law regarding non-use cancellation proceedings and new fee system
22 Apr 2025
0
Commentary on the newly enacted regulation and communiqué recently published in Türkiye concerning non-use cancellations...
READ MORE
There are many questions regarding the road forwards for AI and patents...
READ MORE
On 20 January 2025, the newly inaugurated US President signed an Executive Order entitled “Ending Radical...
READ MORE
Discussing five cloud-based solutions that provide high functionality and easy user accessibility without requiring significant IT...
READ MORE
Experienced FICPI members give insights into what they wish they had known earlier...
READ MORE
Analysing the results of PMC’s AI tools survey
21 Jan 2025
0
Highlights from FICPI Practice Management Committee's (PMC) survey on the use of Artificial Intelligence (AI) in...
READ MORE
BECOME A MEMBER OF FICPI
FICPI is the only international NGO whose membership consists exclusively of IP attorneys in private practice. As a result, the FICPI community is driven by a shared interest to promote solutions and advocacy for private IP practitioners.